GLP1R and obesity disorder: Multi-modal anti-obesity medication treatment appears to be superior to non-pharmacologic medically supervised weight loss or GLP-1 monotherapy for preoperative weight loss in patients with BMI ≥ 70 kg/m2, suggesting that multiple AOMs in the appropriately selected patient may yield significantly greater pre-operative weight loss.